Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07218263 · ClinicalTrials.gov registry record
AI Platform for Fatigue and Depression Detection
A clinical trial of Depression Disorders and Cardiovascular, sponsored by Brijesh Patel.
- Recruiting
- Registry status
- 100
- Enrollment target
- 2
- Study locations
NCT07218263: Recruiting study of Depression Disorders and Cardiovascular, sponsored by Brijesh Patel.
NCT07218263 is a study of Depression Disorders and Cardiovascular that is actively recruiting participants, run by Brijesh Patel. The registered enrollment target is 100 participants, below the 528-participant average among 10 other Depression Disorders trials with a reported enrollment target (81% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07218263, a study of Depression Disorders and Cardiovascular, is actively recruiting participants, sponsored by Brijesh Patel.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 2
- Study locations
Study Summary
This observational study evaluates the accuracy of the Okaya AI platform in detecting fatigue and depression in cardiology patients, comparing its assessments to PHQ-9 and Fatigue Assessment Scale scores.
Primary Outcome
Regression analysis comparing Okaya scores to PHQ-9
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Participants will complete PHQ-9, FAS, and Okaya assessments.
Study Locations (2)
Indiana
- Indiana University - Indianapolis
- Methodist Hospital - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-12-01 |
| Est. Completion | 2026-05 |
What NCT07218263 shows while recruiting
NCT07218263 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 528-participant average among 10 other Depression Disorders trials with a reported enrollment target (81% lower).
The record links to 3 conditions, with Depression Disorders appearing as the primary indexed condition, and to 1 intervention - of which Participants will complete PHQ-9, FAS, and Okaya assessments. is the first listed.
NCT07218263 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT07218263 about?
NCT07218263 is a clinical study titled "AI Platform for Fatigue and Depression Detection". This observational study evaluates the accuracy of the Okaya AI platform in detecting fatigue and depression in cardiology patients, comparing its assessments to PHQ-9 and Fatigue Assessment Scale scores.
What is the current status of trial NCT07218263?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2025-12-01. Estimated completion is 2026-05.
What conditions does trial NCT07218263 study?
This clinical trial studies the following conditions: Depression Disorders, Cardiovascular, Fatigue Symptom.
What interventions are being tested in trial NCT07218263?
The interventions under investigation include: Participants will complete PHQ-9, FAS, and Okaya assessments. (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07218263?
This trial is sponsored by Brijesh Patel, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07218263 being conducted?
This trial has 2 study locations across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07218263's enrollment target sits among peer trials
100 7th of 10 higher than 4 of 10 other Depression Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
RECRUITING · Phase 3
-
Teen Recovery Through Inspiration, Support, and Empowerment
RECRUITING · NA
-
Technology Exposure and Child Health: Wellness Impact and Social Effects: an Observational Product Registry Study
RECRUITING
-
Comparing the Efficacy of Heated Yoga and Sauna as a Treatment for Depression
RECRUITING · NA
-
Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device
RECRUITING
-
Recovery Through Inspiration, Support, and Empowerment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI